Thousands of patients each year have come to rely on the expertise, dedication and compassion of Regional Cancer Care Associates with locations in New Jersey, Connecticut, Massachusetts and the Washington, D.C., area.
RCCA’s commitment to providing excellent care shows in every aspect of the work these physicians do. It is why RCCA has been successful, and why its physicians are routinely selected as the top in their field.
This year, 11 doctors from RCCA were honored as 2025 Top Doctors in Women’s Health as selected by health care research and information company Castle Connolly. The selection process is not only independent, but exhaustive, and includes peer nomination, research, review and screening by America’s most trusted source for finding top doctors.
Using cutting-edge therapies, sophisticated diagnostics, and a warm, personal approach, physicians at Regional Cancer Care Associates’ 19 New Jersey locations treat their patients in a supportive and hopeful environment.
Most importantly, RCCA delivers this care close to a patient’s home, easing the burden for those who would rather not travel to New York or Philadelphia. Loved ones can instead focus on providing support and strength, while patients can focus on healing. Additionally, a Journal of Clinical Oncology showed that receiving cancer care close to home reduces hospitalizations.
The physicians named to Castle Connolly’s prestigious list of 2025 Top Doctors in Women’s Health in New Jersey are:
Of the 850,000 practicing physicians in the U.S., just 7% are named to the Top Doctors list. The recognition is given following a comprehensive review process conducted by an experienced medical review board. Reviewers consider a doctor’s skills, professionalism, training/qualifications, experience, competence, outcomes and achievements as well as his or her relational skills and empathy toward patients.
RCCA has more than 100+ cancer specialists who treat patients in 26 RCCA care centers in New Jersey, Connecticut, Massachusetts and the Washington, D.C., area. Those oncologists see more than 26,000 new patients each year and provide care to more than 245,000 established patients, collaborating closely with their patients’ other physicians.
RCCA is the top choice of many patients due to the comprehensive services offered by its physicians, including immunotherapies and targeted therapy. Patients also have access to a range of clinical trials. In addition to serving patients who have solid tumors, blood-based cancers, and benign blood disorders such as anemia, RCCA care centers also provide infusion therapy services to people with a number of non-oncologic conditions — including multiple sclerosis, Crohn’s disease, asthma, and rheumatoid arthritis — who take intravenously administered medications.
To learn more about RCCA, call 1-844-346-7222 or contact us.
For more information or to schedule an appointment,
call 844-346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
Medical research has made tremendous strides in improving how oncologists understand and treat cancer. One of the most exciting developments is the use of radiopharmaceuticals.
Breast cancer treatment options vary from patient to patient. Physicians must weigh many factors when considering which approach is best for a particular patient. Those
Prostate cancer treatments are constantly improving. Groundbreaking new medications provide longer survival and fewer side effects than ever before. Keeping track of the advances in
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.
